Chemical & Systems Biology
Cell Signaling
& Physiology
Chemical Biology
Systems Biology
Our Department
CSB Department Chair: Tobias Meyer, Ph.D.; Contact: Jennie Visitacion, 650.724-2971, jenniev@stanford.edu
The Department of Chemical and Systems Biology explores the molecular mechanisms that underlie cellular function and contribute to human disease. Our laboratories emphasize interdisciplinary research that spans the biomedical sciences, including signal transduction, cell cycle regulation, chromatin remodeling, protein homeostasis, metabolism, and cell differentiation. By integrating genetic technologies, biochemical and chemical tools, quantitative measurements, and computational modeling, we strive to deconstruct these complex biological systems, predict emergent behaviors, and translate these discoveries into new medical therapies.
Latest
Joanna Wysocka named HHMI investigator
CSB Professor Joanna Wysocka and Electrical Engineering Professor Krishna Shenoy are the two Stanford University researchers among 26 scientists from 19 institutions newly appointed as Howard Hughes Medical Institute investigators. They were chosen through a competitive selection process from a pool Read More »
- Sequential gene silencing using wavelength-selective caged morpholino oligonucleotides.
- Chemical biology strategies for posttranslational control of protein function.
- Mitochondrial Reactive Oxygen Species at the Heart of the Matter: New Therapeutic Approaches for Cardiovascular Diseases.
- Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain.
- Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo.
- Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states.
CSB Department Chair: Tobias Meyer, Ph.D.; Contact: Jennie Visitacion, 650.724-2971, jenniev@stanford.edu
The Department of Chemical and Systems Biology explores the molecular mechanisms that underlie cellular function and contribute to human disease. Our laboratories emphasize interdisciplinary research that spans the biomedical sciences, including signal transduction, cell cycle regulation, chromatin remodeling, protein homeostasis, metabolism, and cell differentiation. By integrating genetic technologies, biochemical and chemical tools, quantitative measurements, and computational modeling, we strive to deconstruct these complex biological systems, predict emergent behaviors, and translate these discoveries into new medical therapies.
Joanna Wysocka named HHMI investigator
CSB Professor Joanna Wysocka and Electrical Engineering Professor Krishna Shenoy are the two Stanford University researchers among 26 scientists from 19 institutions newly appointed as Howard Hughes Medical Institute investigators. They were chosen through a competitive selection process from a pool Read More »
- Sequential gene silencing using wavelength-selective caged morpholino oligonucleotides.
- Chemical biology strategies for posttranslational control of protein function.
- Mitochondrial Reactive Oxygen Species at the Heart of the Matter: New Therapeutic Approaches for Cardiovascular Diseases.
- Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain.
- Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo.
- Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states.